Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Moderate NMB in Laparoscopic Bariatric Surgery
NCT02703909Phase 4Completed
- Sponsor
- University of Missouri
- Start
- May 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rocuronium in class III obesity (4 arms), sponsored by University of Missouri. Primary endpoint: Surgeon Satisfaction Scale. Started May 2016; status: completed.
02
Drugs
rocuronium
03
Conditions
class III obesity
Beyond the preview
Go deeper on NCT02703909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703909.